We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




A New Approach to Drug Delivery

By Biotechdaily staff writers
Posted on 22 May 2002
A novel system of drug delivery has been developed by scientists that could become a weapon in the fight against vascular diseases and cancer.

The new system allows the controlled delivery of drugs via red blood cells. More...
The cells are loaded with drugs that can then be released on demand at specific sites in the human body by using ultrasound. This technique has a wide range of applications, especially in administering toxic drugs such as those used in chemotherapy. Conventional drugs tend to introduce a drug to the entire circulatory system, which increases the risk of side effects. The new system provides control over where the drugs are released in the body. Developed by scientists at biotechnology company Gendel (Coleraine, Northern Ireland), the new delivery system is now ready to be tested on human subjects.

"What is really exciting is that our system can also be used to deliver novel gene-based drugs that are known to be effective in treating certain diseases buy which cannot be used routinely because of the severe side effects they can cause when administered conventionally,” said Dr. Les Russell, chief executive of Gendel.


New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Steam Sterilizer
Hi Vac II Line
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.